381 related articles for article (PubMed ID: 12684647)
1. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
2. The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Acta Haematol; 2003; 110(1):1-10. PubMed ID: 12975549
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway.
Scholz C; Richter A; Lehmann M; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2005 Oct; 24(47):7031-42. PubMed ID: 16007134
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
Rojewski MT; Körper S; Thiel E; Schrezenmeier H
Oncol Rep; 2004 Feb; 11(2):509-13. PubMed ID: 14719092
[TBL] [Abstract][Full Text] [Related]
6. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced apoptosis of human malignant lymphoma cell lines and its mechanisms.
Lu D; Bai XC; Gui L; Li M; Zheng WS; Han XQ; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):997-1001. PubMed ID: 14559676
[TBL] [Abstract][Full Text] [Related]
8. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway.
Xian M; Ito K; Nakazato T; Shimizu T; Chen CK; Yamato K; Murakami A; Ohigashi H; Ikeda Y; Kizaki M
Cancer Sci; 2007 Jan; 98(1):118-26. PubMed ID: 17129359
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z
Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
11. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Lee YY; Kim BK
Int J Oncol; 2001 Feb; 18(2):249-55. PubMed ID: 11172589
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
Kitamura K; Minami Y; Yamamoto K; Akao Y; Kiyoi H; Saito H; Naoe T
Leukemia; 2000 Oct; 14(10):1743-50. PubMed ID: 11021749
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway.
Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346
[TBL] [Abstract][Full Text] [Related]
14. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
15. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias.
Tabellini G; Tazzari PL; Bortul R; Evangelisti C; Billi AM; Grafone T; Martinelli G; Baccarani M; Martelli AM
Br J Haematol; 2005 Sep; 130(5):716-25. PubMed ID: 16115127
[TBL] [Abstract][Full Text] [Related]
17. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
Sahu GR; Jena RK
Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
[TBL] [Abstract][Full Text] [Related]
18. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F
Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740
[TBL] [Abstract][Full Text] [Related]
19. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
20. Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.
Nolte F; Friedrich O; Rojewski M; Fink RH; Schrezenmeier H; Körper S
FEBS Lett; 2004 Dec; 578(1-2):85-9. PubMed ID: 15581621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]